A framework for the biophysical screening of antibody mutations targeting solvent-accessible hydrophobic and electrostatic patches for enhanced viscosity profiles
Open Access
- 29 May 2024
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 23, 2345-2357
Abstract
The formulation of high-concentration monoclonal antibody (mAb) solutions in low dose volumes for autoinjector devices poses challenges in manufacturability and patient administration due to elevated solution viscosity. Often many therapeutically potent mAbs are discovered, but their commercial development is stalled by unfavourable developability challenges. In this work, we present a systematic experimental framework for the computational screening of molecular descriptors to guide the design of 24 mutants with modified viscosity profiles accompanied by experimental evaluation. Our experimental observations using a model anti-IL8 mAb and eight engineered mutant variants reveal that viscosity reduction is influenced by the location of hydrophobic interactions, while targeting positively charged patches significantly increases viscosity in comparison to wild-type anti-IL-8 mAb. We conclude that most predicted in silico physicochemical properties exhibit poor correlation with measured experimental parameters for antibodies with suboptimal developability characteristics, emphasizing the need for comprehensive case-by-case evaluation of mAbs. This framework combining molecular design and triage via computational predictions with experimental evaluation aids the agile and rational design of mAbs with tailored solution viscosities, ensuring improved manufacturability and patient convenience in self-administration scenarios.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/Y003268/1)
- GlaxoSmithKline
- Engineering and Physical Sciences Research Council (EP/V028960/1)
This publication has 46 references indexed in Scilit:
- Rational design of viscosity reducing mutants of a monoclonal antibody: Hydrophobic versus electrostatic inter-molecular interactionsmAbs, 2015
- In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stabilityProceedings of the National Academy of Sciences, 2014
- Concentration Dependent Viscosity of Monoclonal Antibody Solutions: Explaining Experimental Behavior in Terms of Molecular PropertiesPharmaceutical Research, 2014
- Specific Decrease in Solution Viscosity of Antibodies by Arginine for Therapeutic FormulationsMolecular Pharmaceutics, 2014
- The Role of Amino Acid Sequence in the Self-Association of Therapeutic Monoclonal Antibodies: Insights from Coarse-Grained ModelingThe Journal of Physical Chemistry B, 2013
- The Influence of Charge Distribution on Self-Association and Viscosity Behavior of Monoclonal Antibody SolutionsMolecular Pharmaceutics, 2012
- Factors Affecting the Viscosity in High Concentration Solutions of Different Monoclonal AntibodiesJournal of Pharmaceutical Sciences, 2010
- Medicinal Chemistry and the Molecular Operating Environment (MOE): Application of QSAR and Molecular Docking to Drug DiscoveryCurrent Topics in Medicinal Chemistry, 2008
- Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteinsNature Biotechnology, 2004
- A Comparative Study of the Relationship Between Protein Structure and β-Aggregation in Globular and Intrinsically Disordered ProteinsJournal of Molecular Biology, 2004